App is temporarily unavailable
Downloads
Revenue

Description

《NEJM医学前沿》是《新英格兰医学杂志》(NEJM)集团成员之一,一直以来致力于为中国医生、科学工作者提供前沿、高质的生物医学科学资讯,为了能够给广大用户提供更优质的使用体验,我们对《NEJM医学前沿》APP进行了更新改版。

Screenshots

NEJM医学前沿 FAQ

  • Is NEJM医学前沿 free?

    Yes, NEJM医学前沿 is completely free and it doesn't have any in-app purchases or subscriptions.

  • Is NEJM医学前沿 legit?

    🤔 The NEJM医学前沿 app's quality is mixed. Some users are satisfied, while others report issues. Consider reading individual reviews for more context.

    Thanks for the vote

  • How much does NEJM医学前沿 cost?

    NEJM医学前沿 is free.

  • What is NEJM医学前沿 revenue?

    To get estimated revenue of NEJM医学前沿 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.

User Rating
App is not rated in Portugal yet.
Ratings History

NEJM医学前沿 Reviews

没有适配平板的版本

萧忆吾 on

China

可以出一个适应平板的HD版本么?用平板看很难受

注册不了

飞翔的豆沙包 on

China

点手机,发送验证码没反码,说手机邮箱任填一项,邮箱验证码收到了,过了第一步,到了用户名密码都写好了,也勾选了协议,提交又要填写手机验证码,死循环。。。

无法收到手机验证码

shawngao2010 on

China

无法收到手机验证码

无法注册

月牙湖乐乐 on

China

没有验证码,不能注册

谁用谁知道

cjdiyi on

China

多多更新好文章,加油💪

无法注册

krovshi111 on

China

无法注册,无法输入邮箱及获取验证码

无法输入密码怎么解决啊?登录不了a

jinyizhixia on

China

无法输入密码怎么解决啊?登录不了a

iPad上无法政策使用

gfj)o on

China

仅显示在屏幕中央。适配不及时

用不了

唐毅爱妞妞 on

China

能打开app 但是不能加载内容了,以前可以,现在不行了

页面一半的空白

于山雪 on

China

打开APP后出现页面一半空白的额页面。

NEJM医学前沿 Competitors

Name
梅斯医学 - 医路相伴,成就大医
CSCO
医生汇—医学讲座线上直播
专业医生教学直播互动平台
中华医学期刊
中华医学会优质学术资源集大成者
严道医声
医学文献-临床医生下载文献的好助手
生物谷 - 一站式生物医药科研资讯平台
解螺旋
医生数智化学术成长平台
梅斯医生 — 临床必备工具
MedDic Standard

NEJM医学前沿 Installs

Last 30 days

NEJM医学前沿 Revenue

Last 30 days

NEJM医学前沿 Revenue and Downloads

Gain valuable insights into NEJM医学前沿 performance with our analytics.
Sign up now to access downloads, revenue, and more.
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.